In this Bayesian network meta-analysis, we investigated the cardiovascular toxicity associated with nine FDA-approved VEGFR-TKIs, implicating cardiovascular events risk (all grades and grade 3 or higher), hypertension (all grades and grade 3 or higher), and cardiac injuries. The gene discussed is KDR; the disease is Hypertension.